These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Distribution of p53 alterations in a case of gliomatosis cerebri. Mawrin C; Lins H; Kirches E; Schildhaus HU; Scherlach C; Kanakis D; Dietzmann K Hum Pathol; 2003 Jan; 34(1):102-6. PubMed ID: 12605375 [TBL] [Abstract][Full Text] [Related]
4. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes. Seiz M; Tuettenberg J; Meyer J; Essig M; Schmieder K; Mawrin C; von Deimling A; Hartmann C Acta Neuropathol; 2010 Aug; 120(2):261-7. PubMed ID: 20514489 [TBL] [Abstract][Full Text] [Related]
5. Gliomatosis cerebri: no evidence for a separate brain tumor entity. Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382 [TBL] [Abstract][Full Text] [Related]
10. Histological and genetic diagnosis of gliomatosis cerebri: case report. Yamada SM; Hayashi Y; Takahashi H; Teramoto A; Matsumoto K; Yamada S J Neurooncol; 2001 May; 52(3):237-40. PubMed ID: 11519853 [TBL] [Abstract][Full Text] [Related]
11. Molecular genetic alterations in gliomatosis cerebri: what can we learn about the origin and course of the disease? Mawrin C Acta Neuropathol; 2005 Dec; 110(6):527-36. PubMed ID: 16222524 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of molecular genetic alterations associated with tumor progression in a case of gliomatosis cerebri. Braeuninger S; Schneider-Stock R; Kirches E; Powers JM; Korones DN; Mawrin C J Neurooncol; 2007 Mar; 82(1):23-7. PubMed ID: 16955219 [TBL] [Abstract][Full Text] [Related]